The MPN Consortium holds meetings on a regularly monthly base, where researchers of different departments and clinics related to MPN, as well as guest speakers from all over the world get together.
Meetings 2020 of the MPN -Consortium
Time: 17:30h to 19:00h (approx. four-weekly). Two 25+5 min talks each
(25min talk plus 5 min discussion)
Location: temporarily via Zoom- Meeting
Conference Room of the Med. Clinic I, 3rd floor, in between C4/C5
Inhibition of the IRE1α-XBP1 pathway induces apoptosis in FLT3-ITD+ AML cells and enhances the effect of the FLT3 inhibitor Quizartinib
Analysis of novel specific BRD4 inhibitor analogs for the treatment of myeloproliferative disorders.
03 – 05/ 2020
Break due to Covid19
TNF mediated CML cell survival can be overcome by IKK2 inhibition
The EXSCALATE4CoV (E4C) project
Lipocalin 2 (LCN2) in Hematopoetic and Prostate Cancer
AG Ralf Weißkirchen
PDGF signaling in myelofibrosis and other myeloid proliferative diseases
"Investigation of the role of Tyk2 in IFN-signalling in myeloproliferative neoplasms"
Melatonin - Targeting inflammation and myelofibrosis - A real option?
Identification of CALR Mutant-specific Mechanisms-Focus on cell differentiation in an iPS cell model
Patient Specific iPS Cells for Modeling Bone Marrow Fibrosis and Leukemic Transformation